Proteomics Analysis of Brain Meningiomas in Pursuit of Novel Biomarkers of the Aggressive Behavior
- PMID: 27019568
- PMCID: PMC4807620
- DOI: 10.4172/jpb.1000389
Proteomics Analysis of Brain Meningiomas in Pursuit of Novel Biomarkers of the Aggressive Behavior
Abstract
The aim of this pilot study was to evaluate the use of advanced proteomics techniques to identify novel protein markers that contribute to the transformation of benign meningiomas to more aggressive and malignant subtypes. Multiplex peptide stable isotope dimethyl labelling and nano-LCMS was used to identify and quantify the differentially expressed proteins in WHO Grade I, II and III meningioma tissues. The proteins identified will help elucidate the process of transformation to malignancy and may contribute to improved diagnosis and treatment of these aggressive tumors.
Keywords: Anaplastic meningioma; Atypical meningioma; Biomarkers; Meningioma; Proteomics.
Figures
References
-
- Commins DL, Atkinson RD, Burnett ME. Review of meningioma histopathology. Neurosurg Focus. 2007;23:E3. - PubMed
-
- Doleželová H, Hynková L, Pospíšil P, Kazda T, Slampa P, et al. Therapeutic results of the treatment brain tumors using radiosurgery and stereotactic radiotherapy. Klin Onkol. 2012;25:445–451. - PubMed
-
- Oya S, Kawai K, Nakatomi H, Saito N. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neurosurg. 2012;117:121–128. - PubMed
-
- Heald JB, Carroll TA, Mair RJ. Simpson grade: an opportunity to reassess the need for complete resection of meningiomas. Acta Neurochir (Wien) 2014;156:383–388. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources